Damian Garde

Damian Garde

Creator
0 followers

STAT reporter-at-large on biopharma industry

Lilly's Obesity Drug Cleared, Heats up Novo Rivalry
SocialApr 1, 2026

Lilly's Obesity Drug Cleared, Heats up Novo Rivalry

Eli Lilly’s obesity pill approved by FDA, setting up fierce competition with Novo Nordisk https://t.co/8TyrKyyNYP

By Damian Garde
FDA Standards Threaten Affordable Academic Gene Therapies
SocialMar 31, 2026

FDA Standards Threaten Affordable Academic Gene Therapies

The scientists behind treating Baby KJ say the FDA is imposing standards that could make it too expensive for them — or any academics — to bring such bespoke therapies to approval. https://t.co/OrxMXBVev4

By Damian Garde
Hype Undermines Science, Fuels Unfounded Doubt
SocialMar 31, 2026

Hype Undermines Science, Fuels Unfounded Doubt

"This kind of hype is dangerous. It undermines more serious science and brings into play doubt about data that’s yet to be presented.” https://t.co/43glXqCyx9

By Damian Garde
Europe Braces for Fallout of Trump's Drug Pricing Plan
SocialMar 2, 2026

Europe Braces for Fallout of Trump's Drug Pricing Plan

“Nobody wants to feel cornered:" Europe braces for the fallout of Trump's drug pricing plan https://t.co/HZjZH0mdCU

By Damian Garde
Former Surgeon General Urges Senate Reject Unqualified SG
SocialFeb 27, 2026

Former Surgeon General Urges Senate Reject Unqualified SG

Former surgeon general: The Senate must not approve an SG who can’t practice medicine https://t.co/TfgRw59xFd

By Damian Garde
Global Vaccine Market Persists, but Innovation May Falter
SocialFeb 12, 2026

Global Vaccine Market Persists, but Innovation May Falter

“Yes, the rest of the world can maintain a market for vaccines. But will it be as innovative and as vibrant as it has been? That’s a different question.” https://t.co/jB38FWfglo

By Damian Garde